Pregnancy Clinical Trial
Official title:
Endometrial Mediators of Gonadal Steroid Action
Endometrium is the lining of the uterus. It is where the fertilized egg normally implants
during pregnancy.
This study was designed to better understand the way(s) that female sex hormones (estrogen
and progesterone) cause the uterus to grow and develop. It is known that these hormones are
necessary to prepare the uterus for pregnancy, but the way the hormones work is unknown.
Researchers would like to identify the genes that are affected by female sex hormones by
using a variety of tests (in situ hybridization, immunohistochemistry, and culture of human
endometrium).
Researchers will select women who have regular monthly menstrual cycles and study them for
two cycles;
1. <TAB>The first cycle (PRE-BIOPSY CYCLE) will include daily measurements of the patient's
body temperature and progesterone measurements during the last 14 days (luteal phase) of
the menstrual cycle.
2. <TAB> The second cycle (BIOPSY CYCLE) will include measurements of urinary luteinizing
hormone (LH) to determine the day of the LH surge. Luteinizing hormone is the hormone
that causes the ovary to release the developed egg. Ovarian ultrasounds will be
performed before the biopsy to determine development of the egg. Blood tests will be
taken on the day of the biopsy to have an overall idea of the hormones circulating in
the patient's blood. An endometrial biopsy will be taken at one of three possible times
to identify endometrial products under conditions of estrogen, estrogen/progesterone, or
steroid hormone withdrawal.<TAB>
Estrogen and progesterone induce characteristic and predictable morphological changes in the
endometrium that are required for successful implantation and pregnancy. The mechanism(s) by
which estrogen and progesterone exert these effects on the endometrium is not known. This is
a tissue collection protocol to obtain endometrium and/or menstrual effluent from normally
cycling women, women with endometriosis and women with infertility.
This tissue will be used for future studies intended to understand gonadal steroid action on
the endometrium We propose to identify peptides that are induced by endogenous estrogen and
progesterone using in situ hybridization, immunohistochemistry, microarray analysis and/or
culture of human endometrium obtained at hormonally different times of the cycle. Regularly
cycling women not at risk for pregnancy will be studied for two menstrual cycles. The first,
pre-biopsy cycle, will be characterized by daily basal body temperature measurements and a
luteal phase progesterone measurement. During the biopsy cycle, urinary LH measurements will
be performed to determine the day of the LH surge. Ovarian ultrasounds to assess follicular
development will be performed before biopsy. Blood will be obtained on the day of the biopsy
to characterize the hormonal mileau. An endometrial biopsy will be obtained either in the
early follicular phase (at a follicular diameter of less than 8 mm), the late follicular
phase (follicular diameter greater than 14 mm) or in the mid-(luteal phase day 6-8) or late
(luteal phase day 12 - 14) luteal phase, to allow identification of endometrial products
under conditions of estrogen, estrogen/progesterone and steroid withdrawal. Alternatively,
endometrial tissue may be obtained from normal women and those with endometriosis at the time
of menses using a cup-shaped intravaginal collecting device. Additionally, women with
infertility possibly related to endometrial dysfunction will be studied in the luteal phase.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |